ArticleOncology letters2013

A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma.

Elisa Paolicchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.